Skip to main content

Table 6 Methylation studies in diabetic kidney disease

From: Genomic approaches in the search for molecular biomarkers in chronic kidney disease

PMID

Author

Year

Sample

Cases (n)

Controls (n)

Ethnicity

Methodology

Main findings

25850930

Swan

2015

Blood

DKD (n = 100)

DKD + ESRD (n = 50) RRT

Diabetes and no renal disease (n = 100)

White

27 K

450 K

Mitochondrial Genes

Identification of 450 CpGs differentially methylated

T1DM-DKD: 54 probes (51 genes) significant (p < 10−8)

PMPCB, AUH and TSFM: DMRs at more than one CpG

ESRD: identification of 755 CpG probes in 374 (p ≤ 10−8). Forty-three top-ranked CpG sites for DKD were also differentially methylated identified in the subgroup of patients with ESRD

24098934

Ko

2013

Tubule epithelial cells

Discovery: CKD (both HT and DKD) (n = 14)

Replication: DKD (n = 21)

Discovery: Healthy (n = 14)

Replication: Non-DKD

Mixed

Discovery: MSP-HELP

Replication: MassArray Epityper (INTERNAL) and 450 K (external)

Identification of 4751 DMRs identified in Discovery, 1535 unique genes, 70% showed hypomethylation in CKD

Confirmation of 1061 unique genes were identified in the replication cohort (98% of genes found in the discovery analysis)

COLIVA1, along with 5 other gene loci, had mRNA/protein analyses performed

DMRs enriched in kidney-specific gene regulatory regions (mainly enhancers/binding motifs for renal-specific transcription factors

21150313

Sapienza

2011

Saliva

DM-ESRD (n = 23)

DM (n = 23)

African American

Hispanic American

27 K array 27,578 CpG sites

Due to the small number of patients involved, only genes which had at least two significant CpGs were considered as “candidate” biomarker genes. This yielded 187 genes (389 CpGs)

When Benjamini–Hochberg correction applied, original no. of associated CpGs fell from 2870 (approximately 10%) to 30

20687937

Bell

2010

Blood

DKD (n = 96)

T1DM

Irish

27 K array 27,578 CpG sites

Over 400 differentially methylated CpG sites found (263 conferred increased risk and 162 conferred decreased risk for DKD)

Narrowed down to 19 CpGs when more stringent FDR threshold (0.05) applied

Many genes overlap with Ko et al. (2013) at less stringent threshold, but only one (RUNX3) when FDR threshold reduced to 0.05

  1. AUH: AU RNA binding methylglutaconyl-CoA hydratase; CKD: chronic kidney disease; CpGs: CpG islands or CG islands (5′—C—phosphate—G—3′: cytosine and guanine separated by only one phosphate group); DKD: diabetic kidney disease; DM: diabetes mellitus; DMRs: differentially methylated regions; MSP-HELP: methylation-sensitive and -insensitive isoschizomer enzymes (HpaII and MspI) followed by (HpaII) fragment enrichment by ligation-mediated PCR; HT: hypertension; RRT: renal replacement therapy; T1DM: type 1 diabetes mellitus; PMPCB: peptidase, mitochondrial processing beta subunit; RUNX3: runt related transcription factor 3; TSFM: Ts translation elongation factor; mitochondrial